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Summary
The Gram positive bacterium Streptococcus pyogenes (group A streptococcus; GAS) is
the major etiological agent of a variety of skin and mucosal infections in humans.
Whilst the majority of GAS infection results in only mild, uncomplicated disease, the
migration of GAS from superficial to deep tissue sites can result in invasive infection.
In recent years, there has been a resurgence in severe GAS disease, however, the details
of GAS pathogenesis have yet to be fully elucidated. Increasingly, subversion of the
host plasminogen activation system is being implicated in the virulence of S. pyogenes.
GAS display receptors for the human zymogen plasminogen on the cell surface, one of
which is the plasminogen-binding group A streptococcal M-like protein (PAM). PAM
has been implicated in the pathogenesis of certain GAS isolates, but the mechanism of
plasminogen binding by PAM, and the role of this interaction in the pathogenesis of
GAS, requires further investigation. Thus, the focus of this thesis has been to
characterise plasminogen binding by PAM and a number of naturally occurring PAM
variants.

Characterisation of PAM genes from 13 GAS isolates revealed that whilst these
molecules are highly conserved in the c and d repeat domains, they display significant
variation within the plasminogen binding repeat motifs (a1/a2). Percent identity to the
prototype PAM a1/a2 repeat sequence ranged from 52% to 100% amongst the variants
studied here. No correlation was seen between the presence of a PAM gene, or variation
within the sequence of PAM, and site of GAS isolation. In order to determine the
impact of sequence variation on protein function, recombinant proteins representing six
naturally occurring variants of PAM, together with a recombinant M1 protein were
expressed and purified. Equilibrium dissociation constants for the interaction of PAM
xi

variants with biotinylated glu-plasminogen ranged from 1.58 nM to 7.58 nM. Effective
concentrations of prototype PAM required for 50% inhibition of plasminogen binding to
immobilised PAM variants ranged from 0.34 nM to 22.06 nM. These results suggest
that while variation in the a1/a2 region of the PAM protein does affect the comparative
affinity of PAM variants, the functional capacity to bind plasminogen at physiologically
relevant concentrations is conserved. Additionally, a potential role for the a1 region of
PAM in eliciting a protective immune response was investigated using a mouse model
for GAS infection. The a1 region of PAM was found to protect immunised mice
challenged with a homologous PAM-positive GAS strain. These data suggest a link
between selective immune pressure against the plasminogen-binding repeats and the
functional conservation of the binding domain in PAM variants.

Site-directed mutagenesis of full length PAMNS13 protein from an invasive GAS isolate
was undertaken to assess the contribution of residues in the a1 and a2 repeat domains to
plasminogen binding function. Mutagenesis to alanine of key plasminogen binding site
lysine residues in the a1 and a2 repeats (Lys98 and Lys111) did not abrogate plasminogen
binding by PAM, nor did additional mutagenesis of Arg101, His102 and Glu104, which
have previously been implicated in plasminogen binding by PAM. Plasminogen binding
was only abolished with the additional mutagenesis of Arg114 and His115 to alanine.
Furthermore, mutagenesis of both arginine (Arg101 and Arg114) and histidine (His102 and
His115) residues abolished interaction with plasminogen despite the presence of Lys98
and Lys111 in the binding repeats. This study shows for the first time that residues
Arg101, Arg114, His102 and His115 in both the a1 and a2 repeat domains of PAM can
mediate high affinity plasminogen binding. These data suggest that highly conserved
arginine and histidine residues may compensate for variation elsewhere in the a1 and a2
xii

plasminogen binding repeats, and may explain the maintenance of high affinity
plasminogen binding by naturally occurring variants of PAM.

Initial sequence characterisation of PAM variants in this study revealed a
phylogenetically distinct PAM variant, PAMNS88.2. This variant binds plasminogen with
high affinity (Kd = 7.58 nM), despite displaying only 52% identity to the classical a1/a2
repeat domain of PAM. It was therefore of interest to characterise the putative
plasminogen binding domain of PAMNS88.2. Additionally, the association of GAS strain
NS88.2, from which PAMNS88.2 was isolated, with the invasive disease bacteraemia,
makes it a candidate for virulence studies employing the recently developed human
plasminogen transgenic mouse. Site-directed mutagenesis of the putative plasminogen
binding site indicated that as with PAMNS13, PAMNS88.2 does not interact with
plasminogen exclusively via lysine residues. Mutagenesis to alanine of lysine residues
Lys96 and Lys101 reduced but did not abrogate plasminogen binding by PAMNS88.2.
Plasminogen binding was only abolished with the additional mutagenesis of Arg107 and
His108 to alanine. Furthermore, mutagenesis of Arg107 and His108 abolished plasminogen
binding by PAMNS88.2 despite the presence of Lys96 and Lys101 in the binding site. Given
that GAS strain NS88.2 is associated with the invasive disease bacteraemia, and is
virulent in the humanised plasminogen transgenic mouse, the successful abrogation of
plasminogen binding by PAMNS88.2 may facilitate the development of a PAMNS88.2
allelic replacement isogenic mutant for use in future studies involving this model.

This study examines in detail the interaction of PAM and PAM variants with the human
zymogen plasminogen. The maintenance of plasminogen-binding function in spite of
binding site sequence variation suggests that the ability to interact with plasminogen is
xiii

evolutionarily advantageous to a subset of GAS isolates. Additionally, this study
provides previously unreported details of the ability of PAM to interact with
plasminogen independently of binding site lysine residues. These findings have
implications for both the future identification of novel plasminogen binding proteins,
and may facilitate both the understanding of the role of PAM in GAS disease, and the
development of therapeutics to assist in the treatment and prevention of streptococcal
infection.
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